SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-004129
Filing Date
2020-02-18
Accepted
2020-02-18 16:12:21
Documents
2
Period of Report
2020-02-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k021820_immucellcorp.htm 8-K 16263
2 PRESS RELEASE OF IMMUCELL CORPORATION DATED FEBRUARY 18, 2020 f8k021820ex99-1_immucell.htm EX-99.1 60917
  Complete submission text file 0001213900-20-004129.txt   78269
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 20625422
SIC: 2835 In Vitro & In Vivo Diagnostic Substances